Pyrrho Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Pyrrho Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$504K	Buy	+22,700	New	+$425K	0.76%	29

Other funds holding NDRM

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pyrrho Capital Management's NDRM Position: Q4 2016 in Review

Pyrrho Capital Management opened a new position in NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016: 22,700 shares worth $504K. The stake represents 0.76% of the portfolio and ranks #29 among its holdings.

56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

Pyrrho Capital Management held 22,700 shares of NeuroDerm Ltd. Ordinary Shares worth $504K as of Q4 2016.
NeuroDerm Ltd. Ordinary Shares was a new Pyrrho Capital Management position in Q4 2016.
NeuroDerm Ltd. Ordinary Shares made up 0.76% of Pyrrho Capital Management's portfolio in Q4 2016, its #29 holding.
56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on Pyrrho Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.